AstraZeneca says COVID-19 vaccine found 79 percent effective in US trial with no safety concerns | The Hill: Healthcare Policy

AstraZeneca announced on Monday that its vaccine was 79 percent effective in preventing symptomatic COVID-19 in Phase III U.S. testing with no safety concerns found.The company also said in a statement that the vaccine was found to be 100 percent...